Duligotuzumab
id:
duligotuzumab-311-13637290
title:
Duligotuzumab
text:
Duligotuzumab (INN) is a bispecific humanized IgG1 monoclonal antibody designed for the treatment of cancer. It acts as an immunomodulator and binds to EGFR and HER3. It is in development by Roche. Clinical development for head and neck cancer and colorectal cancer have been discontinued, but phase I trials in combination with cobimetinib are evaluating safety for treatment of solid tumors.
brand slug:
wiki
category slug:
encyclopedia
description:
Monoclonal antibody
original url:
https://en.wikipedia.org/wiki/Duligotuzumab
date created:
date modified:
2023-04-03T04:20:17Z
main entity:
{"identifier":"Q8329767","url":"https://www.wikidata.org/entity/Q8329767"}
image:
fields total:
13
integrity:
14